Literature DB >> 17435461

Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury in children.

Harvey Levin1, Gerri Hanten, Jeffrey Max, Xiaoqi Li, Paul Swank, Linda Ewing-Cobbs, Maureen Dennis, Deleene S Menefee, Russell Schachar.   

Abstract

METHODS: We investigated changes in inattentive and hyperactive symptoms over 2 years following traumatic brain injury (TBI) in relation to preinjury attention-deficit/hyperactivity disorder (ADHD), injury, and socioeconomic status (SES) variables. Postinjury stimulant medication treatment was also documented. Of 175 consecutive patients of ages 5 to 15 years with acute TBI, 148 consented, including 114 without preinjury ADHD (mean age, 10.0 years, SD = 2.76) and 34 with preinjury ADHD (mean age 10.36 years, SD = 2.75). The Schedule for Affective Disorders and Schizophrenia for School-Age Children, Present and Lifetime Version, was administered at baseline and at 6, 12, and 24 months post-injury to assess the presence of nine core inattentive and nine hyperactive symptoms and associated impairment. The baseline assessment was performed within 1 month post-injury to establish preinjury diagnosis.
RESULTS: Nonlinear change in inattentive symptoms in patients without preinjury ADHD contrasted with higher and more stable symptom levels in children with preinjury diagnosis, including the cubic trend (chi2(1) = 6.23, p = .0126). There was also a significant interaction of group x gender effect (chi2(1) = 4.08, p = .0435) as males had higher numbers of inattentive symptoms than females in the preinjury ADHD group. Change in hyperactive symptoms over time also differed by group, including both linear (chi2(1) = 5.42, p = .0199) and cubic trends (chi2(1) = 8.91, p = .0029), reflecting greater and more frequent fluctuations in children without preinjury ADHD. Socioeconomic level also contributed to change in hyperactive symptoms as reflected by the interaction of SES and linear time (chi2(1) = 6.91, p = .009), as well as quadratic time (chi2(1) = 4.90, p = .027). Occurrence of ADHD diagnosed post-injury ranged from 14.5% (12 months) to 18.3% (24 months) in the group without preinjury ADHD compared with a range from 86.4% (12 months) to 96.2% (6 months) in children with preinjury ADHD. In children without preinjury ADHD, SES was the only patient variable that predicted onset of ADHD, t(110) = -2.85, p = .0052. Treatment with stimulant medication post-injury was more frequently associated with preinjury ADHD (39% vs 7% of children without preinjury ADHD), p< .0001 (Fisher exact test). Children with preinjury ADHD who were treated pre-injury with stimulant medication had fewer total symptoms at 24 months post-injury relative to untreated patients with preinjury ADHD (F[1,14] = 3.93, p = 0.069, Cohen's d = 1.28).
CONCLUSION: Change in ADHD symptoms after TBI varies with preinjury diagnosis, reflects injury severity in children without preinjury ADHD, and is treated with stimulant medication mainly in those patients with preinjury ADHD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435461     DOI: 10.1097/01.DBP.0000267559.26576.cd

Source DB:  PubMed          Journal:  J Dev Behav Pediatr        ISSN: 0196-206X            Impact factor:   2.225


  31 in total

1.  Neuropsychological performance of youth with secondary attention-deficit/hyperactivity disorder 6- and 12-months after traumatic brain injury.

Authors:  Tisha J Ornstein; Sanya Sagar; Russell J Schachar; Linda Ewing-Cobbs; Sandra B Chapman; Maureen Dennis; Ann E Saunders; Tony T Yang; Harvey S Levin; Jeffrey E Max
Journal:  J Int Neuropsychol Soc       Date:  2014-11       Impact factor: 2.892

Review 2.  The effect of pediatric traumatic brain injury on behavioral outcomes: a systematic review.

Authors:  Linda Li; Jianghong Liu
Journal:  Dev Med Child Neurol       Date:  2012-09-23       Impact factor: 5.449

Review 3.  Interventions for attention problems after pediatric traumatic brain injury: what is the evidence?

Authors:  Barynia Backeljauw; Brad G Kurowski
Journal:  PM R       Date:  2014-04-19       Impact factor: 2.298

4.  Cognitive recovery and development after traumatic brain injury in childhood: a person-oriented, longitudinal study.

Authors:  Catherine Aaro Jonsson; Cathy Catroppa; Celia Godfrey; Ann-Charlotte Smedler; Vicki Anderson
Journal:  J Neurotrauma       Date:  2013-01-15       Impact factor: 5.269

5.  Inhibitory control after traumatic brain injury in children.

Authors:  Katia J Sinopoli; Maureen Dennis
Journal:  Int J Dev Neurosci       Date:  2011-11-11       Impact factor: 2.457

6.  Long-Term Neuropsychological Profiles and Their Role as Mediators of Adaptive Functioning after Traumatic Brain Injury in Early Childhood.

Authors:  Amery Treble-Barna; Huaiyu Zang; Nanhua Zhang; H Gerry Taylor; Keith Owen Yeates; Shari Wade
Journal:  J Neurotrauma       Date:  2016-05-09       Impact factor: 5.269

7.  Cognitive, affective, and conative theory of mind (ToM) in children with traumatic brain injury.

Authors:  Maureen Dennis; Nevena Simic; Erin D Bigler; Tracy Abildskov; Alba Agostino; H Gerry Taylor; Kenneth Rubin; Kathryn Vannatta; Cynthia A Gerhardt; Terry Stancin; Keith Owen Yeates
Journal:  Dev Cogn Neurosci       Date:  2012-11-23       Impact factor: 6.464

8.  Gender and injuries predict stimulant medication use.

Authors:  Søren Dalsgaard; James F Leckman; Helena Skyt Nielsen; Marianne Simonsen
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05-09       Impact factor: 2.576

9.  Theory of mind in children with traumatic brain injury.

Authors:  Maureen Dennis; Nevena Simic; H Gerry Taylor; Erin D Bigler; Kenneth Rubin; Kathryn Vannatta; Cynthia A Gerhardt; Terry Stancin; Caroline Roncadin; Keith Owen Yeates
Journal:  J Int Neuropsychol Soc       Date:  2012-07-30       Impact factor: 2.892

Review 10.  Puppets, robots, critics, and actors within a taxonomy of attention for developmental disorders.

Authors:  Maureen Dennis; Katia J Sinopoli; Jack M Fletcher; Russell Schachar
Journal:  J Int Neuropsychol Soc       Date:  2008-09       Impact factor: 2.892

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.